Cargando…

MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent

Metastasis is the primary cause of death in breast cancer patients. Early detection of high-risk breast cancer, including micrometastasis, is critical in tailoring appropriate and effective interventional therapies. Increased fibronectin expression, a hallmark of epithelial-to-mesenchymal transition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhuxian, Qutaish, Mohammed, Han, Zheng, Schur, Rebecca M., Liu, Yiqiao, Wilson, David L., Lu, Zheng-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557274/ https://www.ncbi.nlm.nih.gov/pubmed/26264658 http://dx.doi.org/10.1038/ncomms8984

Ejemplares similares

Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases
por: Qutaish, Mohammed Q., et al.
Publicado: (2018)

Quantitative analysis of metastatic breast cancer in mice using deep learning on cryo-image data
por: Liu, Yiqiao, et al.
Publicado: (2021)

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2008)

A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009)

The immunocytochemical detection of axillary micrometastases in breast cancer.
por: Wells, C. A., et al.
Publicado: (1984)

Lung Micrometastases Display ECM Depletion and Softening While Macrometastases Are 30-Fold Stiffer and Enriched in Fibronectin
por: Narciso, Maria, et al.
Publicado: (2023)

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome
por: Naume, B, et al.
Publicado: (2005)

High-precision detection and navigation surgery of colorectal cancer micrometastases
por: Ma, Shengjie, et al.
Publicado: (2023)

Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses
por: Ayat, Nadia R., et al.
Publicado: (2019)

Identification of novel drugs to target dormant micrometastases
por: Hurst, Robert E., et al.
Publicado: (2015)

Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
por: Kerboeuf, Mikael, et al.
Publicado: (2021)

Prognostic significance of further axillary dissection in breast cancer patients with micrometastases & the number of micrometastases: a SEER population-based analysis
por: Ying-Ying, Liu, et al.
Publicado: (2018)

Radioimmunotherapy of micrometastases in lung with vascular targeted(213)Bi
por: Kennel, S J, et al.
Publicado: (1999)

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.
por: Trojani, M., et al.
Publicado: (1987)

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
por: Choesmel, Valérie, et al.
Publicado: (2004)

Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent
por: Abou-Elkacem, Lotfi, et al.
Publicado: (2016)

Does surgery modify growth kinetics of breast cancer micrometastases?
por: Demicheli, R, et al.
Publicado: (2001)

Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots
por: Wang, Yali, et al.
Publicado: (2012)

A tumour spheroid model for antibody-targeted therapy of micrometastases.
por: Walker, K. A., et al.
Publicado: (1988)

Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients.
por: Schoenfeld, A., et al.
Publicado: (1996)

Potential Applications of Quantum Dots in Mapping Sentinel Lymph Node and Detection of Micrometastases in Breast Carcinoma
por: Alam, Feroz, et al.
Publicado: (2013)

Micrometastases in sentinel nodes of gastric cancer
por: Ajisaka, H, et al.
Publicado: (2003)

Micrometastases in axillary nodes: Out of the reckoning?
por: Singh, Akshita, et al.
Publicado: (2016)

Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016)

The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.
por: Sloane, J. P., et al.
Publicado: (1980)

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.
por: Trojani, M., et al.
Publicado: (1987)

Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
por: Falzone, Nadia, et al.
Publicado: (2019)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009)

Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218
por: Li, Yajuan, et al.
Publicado: (2022)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Gadonanotubes as new high-performance MRI contrast agents
por: Sitharaman, Balaji, et al.
Publicado: (2006)

Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases
por: Chen, Wei-Rong, et al.
Publicado: (2019)

Inherently Multimodal Nanoparticle-Driven Tracking and Real-Time Delineation of Orthotopic Prostate Tumors and Micrometastases
por: Liu, Tracy W., et al.
Publicado: (2013)

MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles
por: Sun, Yujin, et al.
Publicado: (2014)

Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases
por: Tan, Shanshan, et al.
Publicado: (2020)

Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent
por: Ibhagui, Oluwatosin Y., et al.
Publicado: (2023)

Quantitative evaluation of contrast agent uptake in standard fat‐suppressed dynamic contrast‐enhanced MRI examinations of the breast
por: Kousi, Evanthia, et al.
Publicado: (2017)

Prognostic Value of Lymph Node Micrometastases in Breast Cancer: A Multicenter Cohort Study
por: Gobardhan, Paul D., et al.
Publicado: (2010)

Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer
por: Oakman, Catherine, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ts8n29ldo29u2u4dgp18sibpck